Asia Leaders
Shinya Yamanaka Built Japan’s iPS Infrastructure. Personalised Cell Therapy Must Now Clear the Cost Barrier
Shinya Yamanaka has spent two decades turning cellular reprogramming into shared infrastructure. His next test is whether patient-specific iPS cells can be made reliably and cheaply enough for Asian health systems.
